Literature DB >> 32786282

Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health.

Camila Fontoura Acosta Ribeiro1, Gislaine Greice de Oliveira Silva Silveira1, Elizabete de Souza Cândido1,2, Marlon Henrique Cardoso1,2, Cristiano Marcelo Espínola Carvalho1, Octávio Luiz Franco1,2.   

Abstract

The need for new antimicrobial therapies is evident, especially to reduce antimicrobial resistance and minimize deleterious effects on gut microbiota. However, although diverse studies discuss the adverse effects of broad-spectrum antibiotics on the microbiome ecology, targeted interventions that could solve this problem have often been overlooked. The impact of antibiotics on gut microbiota homeostasis is alarming, compromising its microbial community and leading to changes in host health. Recent studies have shown that these impacts can be transient or permanent, causing irreversible damage to gut microbiota. The responses to and changes in the gut microbial community arising from antibiotic treatment are related to its duration, the number of doses, antibiotic class, host age, genetic susceptibility, and lifestyle. In contrast, each individual's native microbiota can also affect the response to treatment as well as respond differently to antibiotic treatment. In this context, the current challenge is to promote the growth of potentially beneficial microorganisms and to reduce the proportion of microorganisms that cause dysbiosis, thus contributing to an improvement in the patient's health. An essential requirement for the development of novel antibiotics will be personalized medicinal strategies that recognize a patient's intestinal and biochemical individuality. Thus, this Review will address a new perspective on antimicrobial therapies through pathogen-selective antibiotics that minimize the impacts on human health due to changes in the gut microbiota from the use of antibiotics.

Entities:  

Keywords:  antibiotics; antimicrobial therapies; bacterial diversity; dysbiosis; gut microbiota; microbial interaction; nontraditional antimicrobial therapies

Mesh:

Substances:

Year:  2020        PMID: 32786282     DOI: 10.1021/acsinfecdis.0c00036

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  11 in total

Review 1.  Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria.

Authors:  Kristen A Muñoz; Paul J Hergenrother
Journal:  Acc Chem Res       Date:  2021-02-26       Impact factor: 22.384

Review 2.  Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

Authors:  Monika Gawałko; Thomas A Agbaedeng; Arnela Saljic; Dominik N Müller; Nicola Wilck; Renate Schnabel; John Penders; Michiel Rienstra; Isabelle van Gelder; Thomas Jespersen; Ulrich Schotten; Harry J G M Crijns; Jonathan M Kalman; Prashanthan Sanders; Stanley Nattel; Dobromir Dobrev; Dominik Linz
Journal:  Cardiovasc Res       Date:  2022-08-24       Impact factor: 13.081

3.  Selective treatment of intracellular bacterial infections using host cell-targeted bioorthogonal nanozymes.

Authors:  Joseph Hardie; Jessa Marie Makabenta; Aarohi Gupta; Rui Huang; Roberto Cao-Milán; Ritabrita Goswami; Xianzhi Zhang; Parvati Abdulpurkar; Michelle E Farkas; Vincent M Rotello
Journal:  Mater Horiz       Date:  2022-05-10       Impact factor: 15.717

Review 4.  Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges.

Authors:  Gabriel Horta-Baas; Antonio Sandoval-Cabrera; María Del Socorro Romero-Figueroa
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

Review 5.  Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence.

Authors:  Natalia Vallianou; Maria Dalamaga; Theodora Stratigou; Irene Karampela; Christina Tsigalou
Journal:  Curr Obes Rep       Date:  2021-05-04

Review 6.  The microbial ecology of Escherichia coli in the vertebrate gut.

Authors:  Ebenezer Foster-Nyarko; Mark J Pallen
Journal:  FEMS Microbiol Rev       Date:  2022-05-06       Impact factor: 15.177

Review 7.  Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases.

Authors:  Md Rayhan Mahmud; Sharmin Akter; Sanjida Khanam Tamanna; Lincon Mazumder; Israt Zahan Esti; Sanchita Banerjee; Sumona Akter; Md Rakibul Hasan; Mrityunjoy Acharjee; Md Sajjad Hossain; Anna Maria Pirttilä
Journal:  Gut Microbes       Date:  2022 Jan-Dec

8.  Improved gut microbiome recovery following drug therapy is linked to abundance and replication of probiotic strains.

Authors:  Jamie FitzGerald; Shriram Patel; Julia Eckenberger; Eric Guillemard; Patrick Veiga; Florent Schäfer; Jens Walter; Marcus J Claesson; Muriel Derrien
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 9.  Impacts of Gut Microbiota on the Immune System and Fecal Microbiota Transplantation as a Re-Emerging Therapy for Autoimmune Diseases.

Authors:  Ashenafi Feyisa Beyi; Michael Wannemuehler; Paul J Plummer
Journal:  Antibiotics (Basel)       Date:  2022-08-12

Review 10.  Gram-negative bacteria and their lipopolysaccharides in Alzheimer's disease: pathologic roles and therapeutic implications.

Authors:  Hyeon Soo Kim; Sujin Kim; Soo Jung Shin; Yong Ho Park; Yunkwon Nam; Chae Won Kim; Kang Won Lee; Sung-Min Kim; In Duk Jung; Hyun Duk Yang; Yeong-Min Park; Minho Moon
Journal:  Transl Neurodegener       Date:  2021-12-07       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.